| Authors: |
Leslie J; Newcastle Fibrosis Research Group, Bioscience Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Krishnamurthy KA; Roger Williams Institute of Liver Studies, School of Immunology & Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Foundation for Liver Research and King's College Hospital, London, UK., Gopalsamy IK; M3 Research Center for Malignome, Metabolome and Microbiome, Institute for Interdisciplinary Research on Cancer Metabolism and Chronic Inflammation, Faculty of Medicine, University of Tübingen, Tübingen, Germany.; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Inacio P; Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany., Huch M; Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany., Gallage S; M3 Research Center for Malignome, Metabolome and Microbiome, Institute for Interdisciplinary Research on Cancer Metabolism and Chronic Inflammation, Faculty of Medicine, University of Tübingen, Tübingen, Germany. Suchira.Gallage@med.uni-tuebingen.de.; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. Suchira.Gallage@med.uni-tuebingen.de., Oakley F; Newcastle Fibrosis Research Group, Bioscience Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. fiona.oakley@ncl.ac.uk., Vacca M; Roger Williams Institute of Liver Studies, School of Immunology & Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Foundation for Liver Research and King's College Hospital, London, UK. michele.vacca@uniba.it.; Clinica Medica 'Cesare Frugoni', Interdisciplinary Department of Medicine, University of Bari 'Aldo Moro', Bari, Italy. michele.vacca@uniba.it.; National Institute for Biostructure and Biosystems (INBB), Rome, Italy. michele.vacca@uniba.it. |
